Company profile for Clarus Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our approach is comprehensive, our thinking is breakthrough, and our outcomes are people‑first. The Clarus Therapeutics team is dedicated to addressing unmet medical needs through the creation of androgen replacement and metabolic therapies. But we look beyond just creating new and better treatments. We seek to alter the treatment journey from start to finish. We won’t stop until we unite the right to feel better, with th...
Our approach is comprehensive, our thinking is breakthrough, and our outcomes are people‑first. The Clarus Therapeutics team is dedicated to addressing unmet medical needs through the creation of androgen replacement and metabolic therapies. But we look beyond just creating new and better treatments. We seek to alter the treatment journey from start to finish. We won’t stop until we unite the right to feel better, with the right to live better.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
555 Skokie Boulevard Suite 340 Northbrook, IL 60062
Telephone
Telephone
(847) 562-4300
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2022/10/18/2536906/19989/en/Clarus-Therapeutics-Holdings-Inc-Announces-Completion-of-Auction-for-Sale-of-JATENZO-and-Selection-of-Tolmar-Inc-as-Successful-Bidder.html

GLOBENEWSWIRE
18 Oct 2022

https://www.globenewswire.com/news-release/2022/09/06/2509977/19989/en/Clarus-Therapeutics-Holdings-Inc-Announces-Plan-for-Near-Term-Sale-of-JATENZO-Using-Structured-Process-Through-Chapter-11-of-the-U-S-Bankruptcy-Code.html

GLOBENEWSWIRE
05 Sep 2022
Clarus' fate in limbo as lead drug Jatenzo sputters
Clarus' fate in limbo as lead drug Jatenzo sputters

20 Aug 2022

// Fraiser Kansteiner FIERCEPHARMA

https://www.fiercepharma.com/pharma/clarus-future-looks-hazy-its-pandemic-era-launch-jatenzo-falters-triggering-layoffs-and-rd

Fraiser Kansteiner FIERCEPHARMA
20 Aug 2022

https://www.globenewswire.com/news-release/2022/08/18/2501238/19989/en/Clarus-Therapeutics-Reports-Second-Quarter-2022-Financial-and-Operating-Results-and-Announces-Workforce-Reduction.html

GLOBENEWSWIRE
18 Aug 2022

https://www.globenewswire.com/news-release/2022/07/28/2487949/19989/en/Clarus-Therapeutics-Announces-Notice-of-Allowance-for-Additional-Patent-Claims-Covering-JATENZO-testosterone-undecanoate.html

GLOBENEWSWIRE
28 Jul 2022

https://www.globenewswire.com/news-release/2022/06/09/2459788/19989/en/Clarus-Therapeutics-to-Present-New-Data-for-JATENZO-testosterone-undecanoate-at-ENDO-2022-the-Endocrine-Society-s-Annual-Meeting.html

GLOBENEWSWIRE
09 Jun 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty